Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA
Introduction
Pregnancy associated malaria (PAM), a substantial cause of disease and death in pregnant women and newborns, is associated with a unique subset of Plasmodium falciparum-infected erythrocytes (IE) that bind chondroitin sulfate A (CSA) in the placenta [1], [2], [3]. Pregnant women acquire protective antibodies that cross-react with geographically diverse placental isolates [4], [5], [6] suggesting that surface molecule(s) expressed by PAM infected erythrocytes have conserved epitopes and, thus, that a PAM vaccine may be possible.
The specific targets of PAM immunity are currently being investigated, but recent evidence suggests that VAR2CSA, a member of the P. falciparum erythrocyte membrane 1 (PfEMP1) protein family, may have an important role in PAM disease and immunity [7]. PfEMP1 proteins are clonally variant parasite adhesion ligands expressed at the surface of infected erythrocytes [8]. Each parasite genome encodes approximately 60 different PfEMP1 proteins, or var genes, but only expresses one PfEMP1 protein at a time [9]. The var2CSA gene is unusual for the var gene family because it is found in all parasite isolates and has been shown to be transcriptionally upregulated in both placental isolates [10], [11] and laboratory parasites selected to bind CSA [12]. VAR2CSA contains multiple CSA binding Duffy binding-like (DBL) domains [13] and appears to be one of the few or only PfEMP1 proteins mediating CSA binding because parasites in which the gene is experimentally disrupted lose the ability to adhere strongly to CSA [14], [15]. Furthermore, VAR2CSA is the target of maternal antibodies [16], [17], [18], [19] making it the leading candidate for a pregnancy malaria vaccine.
Because the VAR2CSA protein displays extensive sequence and antigenic polymorphism [12], [16], [17], [20], [21], designing an effective PAM vaccine will likely require detailed understanding of VAR2CSA sequence, structural and geographic variation. The three-dimensional structures for DBL domains contained in the binding regions of two different erythrocyte binding ligands involved in erythrocyte invasion were recently solved [22], [23]. Despite limited sequence similarity, these domains were found to have highly related structures suggesting that all DBL domains, including those in VAR2CSA, may share a similar structure. This opens up new opportunities to investigate how VAR2CSA [16], [17], and PfEMP1 proteins in general, have evolved as immunoevasive binding ligands [24].
A challenge of studying evolution of var2CSA, (and other highly recombinogenic gene families), is that recombination reduces the effectiveness of traditional phylogenetic approaches, which assume evolution via point mutation [25]. An additional practical complication is that var2CSA is large (∼10 kb), and consequently most gene comparisons have relied on small gene fragments. An important problem in computation biology is discovering correlations among nearby positions in amino acid or DNA alignments. The immune system, for example, recognizes short stretches of amino acids in pathogen proteins. Thus, understanding patterns of sequence diversity is important in vaccine design. In this study, we amplified full-length VAR2CSA sequences from a global collection of parasite isolates and applied novel “recombination aware” computational methods and molecular modeling to investigate the diversity of VAR2CSA.
Section snippets
Parasite isolates
Genomic DNAs in this study were prepared from culture adapted parasite isolates that were previously published [26].
Amplification and sequencing of var2CSA sequences
Nearly complete or full-length var2CSA sequences were amplified from 10 different parasites isolates (Table S1) representing South East Asia (five isolates), East or West Africa (four isolates) or Central or South America (two isolates) using previously defined PCR conditions [20]. In brief, var2CSA sequences were amplified in a process of trial and error in two to five
VAR2CSA DBL domains are structured into variable and semi-conserved blocks
Whereas VAR2CSA is the primary candidate for a PAM vaccine, relatively limited sequence information exists and most of this is partial gene fragments concentrated in only a small part of the protein. To acquire information about how VAR2CSA has diversified, we amplified full or nearly full-length var2CSA sequences from 10 parasite isolates from around the world, and collected all of the partial or complete var2CSA sequences present in GenBank or at P. falciparum genome sequencing projects (
Concluding remarks
Our findings support a model of VAR2CSA evolution in which protein diversification is concentrated at flexible loops in the DBL fold and other surface exposed residues. Unexpectedly, there are extensive local correlations in VAR2CSA polymorphism and the same variable loop types were found in geographically diverse parasite isolates. Comparison to P. reichenowi suggests the polymorphic segments have ancient origins highlighting the importance of gene recombination/gene conversion in var2CSA
Acknowledgements
This research was supported by the Bill & Melinda Gates Foundation (J.D.S.), European Malaria Vaccine Initiative (B.G.) (grant no. 01/2005), and by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. VAR2CSA sequence data for the HB3 and Ghana isolates were obtained from the Plasmodium falciparum HB3 Sequencing Project [Broad Institute of Harvard and MIT (http://www.broad.mit.edu)] and from the P. falciparum Ghana isolate at The Wellcome Trust
References (44)
- et al.
The sick placenta—the role of malaria
Placenta
(2004) - et al.
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria
Lancet
(2004) - et al.
Activation, silencing and mutually exclusive expression within the var gene family of Plasmodium falciparum
Int J Parasitol
(2006) - et al.
VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum
Mol Biochem Parasitol
(2006) - et al.
Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria
Mol Biochem Parasitol
(2006) - et al.
Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum
Cell
(2005) - et al.
Disguising itself--insights into Plasmodium falciparum binding and immune evasion from the DBL crystal structure
Mol Biochem Parasitol
(2006) - et al.
An all-atom distance-dependent conditional probability discriminatory function for protein structure prediction
J Mol Biol
(1998) - et al.
A graph-theoretic algorithm for comparative modeling of protein structure
J Mol Biol
(1998) - et al.
Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family
Mol Biochem Parasitol
(2000)
Analysis of Plasmodium falciparum PfEMP-1/var genes suggests that recombination rearranges constrained sequences
Mol Biochem Parasitol
Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties
J Infect Dis
Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta
Science
Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns
Infect Immun
Maternal antibodies block malaria
Nature
Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines
J Exp Med
The pathogenic basis of malaria
Nature
Transcribed var genes associated with placental malaria in Malawian women
Infect Immun
High level of var2csa transcription by Plasmodium falciparum isolated from the placenta
J Infect Dis
Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria
Mol Microbiol
Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites
J Infect Dis
A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A
EMBO Rep
Cited by (103)
Monoclonal antibodies for malaria prevention
2022, Molecular TherapyEvaluating the performance of drug-repurposing technologies
2022, Drug Discovery TodayStructural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
2021, International Journal of Infectious DiseasesPreclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
2019, EBioMedicineCitation Excerpt :VAR2CSA is a high molecular weight protein with a 300 kDa extracellular region, organized in 6 Duffy-binding like (DBL) domains and a cystein-rich interdomain region (CIDR) also termed inter-domain 1 (ID1), the N-terminal region ID1-DBL2-ID2 forming the minimal CSA-binding domain [18,19]. Var2csa orthologues are conserved among parasite isolates and strains but the relatively high degree of protein sequence polymorphisms represents a challenge for vaccine design [20]. Nevertheless, several studies demonstrated that immunoglobulins from anti-sera raised against VAR2CSA recombinant proteins were able to recognize IEs from placental origins but also to block their adhesion to CSA [21–24].
- 1
Present address: Sun Yat-sen University, Guangzhou, PR China.